Member Info for LovableLumax

Amusing. The raise was nearly a year ago and at 95p yet we sit comfortably above and have only been below a very short period so calling it death spiral ridiculous. The shorters will continue pushing the narrative they always do regardless of what's happening.

I doubt it as they had nearly 3.8m shares. That said it it depends if they are keeping some or selling all. Either way they seem to be selling responsibly so I don't think it's a drama.

75 on the hourly and 4 hourly and 70 on the daily does it for me. We'll see.

At a basic level it is now overbought, RSI, MACD and SMI looking toppy. Surely a correction south before the next move north.

From advfn -

I think we have an idea re interim report. The main thing is to have 12+ months of cash from June 30 and it will be interesting to see how much cash diagnostics has contributed.

I suspect the share price increasing due to anticipation of cohort 6 news. Remember there are no published papers (as stated by Alastair) on levels of Dox in tumours although fairly simple lab experiments putting Dox in cancer cells provides a very good idea of what's needed which is why we had targets depending on the Dox activity of 25 to 400nM (slide 84 in science day deck).

Looking at cohorts 3 and 4 -

Cohort 3 with 3 biopsies with a wide ranging 496 to 1607nM which averaged 931nM.

Cohort 4 with 2 biopsies averaged 1717nM. Within this we had a lung biopsy which had 2419nM so by far the highest and the target range as stated below is 25-400nM so clearly very positive. The Dox in tumour to plasma ration was as high as 125-1. Who knows what cohorts 5 and 6 have achieved? Exciting times for holders and nervy times for those short. Little wonder no II has a short above 0.5%.

This pullback healthy and inevitable as was and still is overbought on the RSI and SMI so a decent pullkback and consolidation before the next move north welcome and nothing to worry about. I will be adding in the coming weeks and will be driven by TA altough news all important so will buy more either way by first half of October.

Mate I know you have gone big here and I can see why but some of these posts are well OTT and may put potential investors off as look increasingly desperate. I suspect lots of good news to come starting in a month or so and hopefully come the start of Q4 we are near to 3p and when news lands go to a much better market cap. In the meantime posting tenuous posts on LinkedIn isn't doing any favours!

Lose loose money even better.

Loose lose money perhaps.

Hi stargate, yet accumulation on tradingview looks positive as does another move but the short term surely the RSI, KC and SMI suggest overbought and to wait to top up? I'm gladI bought more when I did last week and am waiting to get some more but think a drop imminent before the next move

Can you please put a link up or paste the content at all?

Why would they sell 3p shares now at a massive loss? Unless a distressed seller there is no chance.

The change of P1b is a clear indication they are really happy with what they are seeing so they have brought forward a comparator which illustrates their confidence. The fact that more US sites are opening again suggests Tap and the other US clinicians are happy with what they have been seeing so far. An exciting few weeks and months ahead after a quiet summer.

Yep I'm expecting a big deal in OCT/Nov and a significant move into the 2s and possibly beyond in the run-up so likely towards end of Sept which the weekly chart reinforces. Defo positive to have a higher base before news drops to push comfortably ahead of raise price with a fall-back while profit takers take sell and we consolidate before the next move up. Should be an exciting back end of Sept and beyond.

Good work. I'll be buying more as I get more funds available. As long as I get as many as I want before I reckon end of Oct (Tier 1 deal I doubt earlier) I will be happy. That said I suspect the share price will increase (will inevitable pull-backs) in the run up so the sooner to accumulate the better.

It was so overbought here it looked highly likely to fall (I should’ve been disciplined!) but it’ll be momentary. The weekly chart looks primed.

Yeah, as mentioned I have been here for many years and have been frustrated with all the super partnerships both supply and demand side but of course the thing holding growth was the lack of scale so programmatic will change that. They have lots of good relatiosnhips in place so it's been a matter of time for too long but now the infrastructure in place it will hopefully explode next year as written into budgets Q4 this year to take off next. They'll need to raise money of course but likely end of Q1 next year and assuming many impressive new contracts signed they should do so at a much higher share price.

Cheers 2Phevs. I paid a lot more than I would had have I bought last week but hey ho. Having a look through the presentation told me to bite the bullet now.

Looking at the chart on the hourly, daily and 4 hourly it's a sell as well over-bought but it has been for a while and it continues to rise (with a few chunky sells in a small pull-back). The weekly chart is a stonking buy - the SMI, RSI, MACD and SSL Hybrid all saying buy and looking like a significant turn around.

I bought some more yesyerday having held off as the shorter term charts scream sell but it hasn't drifted so if it does and I paid a little more in the medium/long term it won't matter.

The US patient was dosed 3 weeks after the first UK patient which is not a coincidence. They will have likely dosed at least 2 patients on the day and all being well they will have received their second dose 3 weeks later followed by 2 weeks observation.

But yeah C6 completion could land any day.